Table 2.
Number and percentage of BM metastatic lesions and bone metastases (osteolytic/mixed/osteoblastic) in 35 patients noted on pretreatment F18-FDG-PET/CT scans and in 26 patients noted on posttreatment F18-FDG-PET/CT.
| BM (PET) |
Bone metastases (CT) |
Total (PET/CT) |
Patients (number) | |
|---|---|---|---|---|
| PET/CT1 (number of lesions) |
420 | 1353 | 1773 | 35 |
| PET/CT1 (% of lesions) |
24 | 76 | 100 | 35 |
| PET/CT2 (number of lesions) |
49 | 1185 | 1234 | 26 |
| PET/CT2 (% of lesions) |
4 | 96 | 100 | 26 |
BM = bone marrow, PET/CT1 = pretreatment F18-FDG-PET/CT, PET/CT2 = posttreatment F18-FDG-PET/CT, and F18-FDG PET/CT = fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.